| Literature DB >> 28555042 |
Vuyolwethu Siyo1, Georgia Schäfer2,3, Roger Hunter4, Andriy Grafov5, Iryna Grafova6, Martin Nieger7, Arieh A Katz8,9, M Iqbal Parker10,11,12, Catherine H Kaschula13.
Abstract
Garlic is a food and medicinal plant that has been used in folk medicine since ancient times for its beneficial health effects, which include protection against cancer. Crushed garlic cloves contain an array of small sulfur-rich compounds such as ajoene. Ajoene is able to interfere with biological processes and is cytotoxic to cancer cells in the low micromolar range. BisPMB is a synthetic ajoene analogue that has been shown in our laboratory to have superior cytotoxicity to ajoene. In the current study we have performed a DNA microarray analysis of bisPMB-treated WHCO1 oesophageal cancer cells to identify pathways and processes that are affected by bisPMB. The most significantly enriched biological pathways as assessed by gene ontology, KEGG and ingenuity pathway analysis were those involving protein processing in the endoplasmic reticulum (ER) and the unfolded protein response. In support of these pathways, bisPMB was found to inhibit global protein synthesis and lead to increased levels of ubiquitinated proteins. BisPMB also induced alternate splicing of the transcription factor XBP-1; increased the expression of the ER stress sensor GRP78 and induced expression of the ER stress marker CHOP/GADD153. CHOP expression was found to be central to the cytotoxicity of bisPMB as its silencing with siRNA rendered the cells resistant to bisPMB. The MAPK proteins, JNK and ERK1/2 were activated following bisPMB treatment. However JNK activation was not critical in the cytotoxicity of bisPMB, and ERK1/2 activation was found to play a pro-survival role. Overall the ajoene analogue bisPMB appears to induce cytotoxicity in WHCO1 cells by activating the unfolded protein response through CHOP/GADD153.Entities:
Keywords: CHOP/GADD153; ER stress; ajoene; cancer prevention; garlic; unfolded protein response
Mesh:
Substances:
Year: 2017 PMID: 28555042 PMCID: PMC6152762 DOI: 10.3390/molecules22060892
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1The ajoene analogue bisPMB is cytotoxic to oesophageal cancer cells. (A) X-ray crystal structure of bisPMB. After crystallization found to be a pure Z-stereoisomer. Table showing structural parameters for =C-S-S-C- moiety in bisPMB. (B) Cytotoxicity quantification. Oesophageal cancer cells (WHCO1, WHCO6 and KYSE30) and a non-cancerous cell line (HET-1A) were treated with bisPMB and cytotoxicity was quantitated by the MTT assay. Extent of inhibition is reported as an IC50 value ± SD of three independent determinations taken after 24 h treatment. (C) Apoptosis quantification. WHCO1 cells were treated with bisPMB at ½ IC50; IC50 or 2 IC50 concentrations and apoptosis was quantified by measuring histone associated DNA fragments in the cytoplasm after treatment. Each bar represents the mean absorbance ± SD of three independent determinations.
Figure 2Transcriptional profiling of WHCO1 oesophageal cancer cells treated with bisPMB. (A) Microarray hierarchical clustering. The hierarchical clustering of genes from the Affymetrix Gene Chip Human Gene 2.0 ST Array consisting of four experimental replicates of control and bisPMB-treated WHCO1 cells. Each gene is represented by a column, and each sample is represented by a row. Expression changes: unchanged (grey), up-regulated (red), down-regulated (blue). (B) Microarray validation. The fold change of 16 DEGs obtained from the microarray (black) were validated by reanalysing the same microarray mRNA by qRT-PCR (grey); and independently by extracting new mRNA from an independent experiment and analysing by qRT-PCR (hashed). All data was normalized relative to GAPDH. (C) Gene network of the ER stress pathway. The DEGs from the microarray are highlighted in green (down-regulated) or red (up-regulated). The cellular compartments are labelled inside the shape demarcating them.
Figure 3bisPMB activates the unfolded protein response in WHCO1 cells. (A) Protein synthesis quantification. WHCO1 cells were treated with bisPMB (IC50 concentration) for 24 h and protein synthesis was quantified fluorometrically using the Click-it HPG Alexa Fluor Protein Synthesis Assay kit. (B) WHCO1 cells were incubated with bisPMB (½ IC50 concentration) for up to 24 h. Total cell lysate was extracted and analysed for GRP-78 expression by immunoblot probed with anti-GRP78 and anti-GAPDH primary antibodies. (C) WHCO1 cells were incubated with bisPMB (½ IC50 concentration) for up to 24 h. Total cell lysate was extracted and examined for total ubiquitination by immunoblot using anti-ubiquitin and anti-GAPDH primary antibodies. (D) Time dependent splicing of XBP1. mRNA was extracted from WHCO1 cells treated with bisPMB (IC50 concentration) for up to 24 h and subjected to qRT-PCR. The XBP-1 spliced (s) and unspliced (u) PCR products were separated on an agarose gel. Immunoblots and gels shown are representative of two independent experiments. The graphs are an average of three independent experiments. Student t-test indicates * p-value < 0.05; ** p-value < 0.01.
Figure 4CHOP knock down reverses bisPMB cytotoxicity in WHCO1 cells. (A) Time-dependent CHOP expression. WHCO1 cells were incubated with bisPMB (IC50 concentration) for 24 h. Total cell lysate was then extracted and examined for time-dependent CHOP protein expression by immunoblot probed with anti-CHOP and anti-GAPDH primary antibodies. (B) Knock-down of CHOP. WHCO1 cells were pre-incubated with siRNA-CHOP or vehicle for 6 h followed by addition of bisPMB (IC50 concentration) for 24 h. Total cell lysate was extracted and examined for CHOP protein expression by immunoblot probed with anti-CHOP and anti-GAPDH primary antibodies. (C) Cell viability quantification. WHCO1 cells were pre-incubated with siRNA-CHOP or vehicle for 6 h followed by addition of bisPMB (IC50 concentration) for 24 h. Cell viability was then quantified by the MTT assay. Each column represents an average of three technical replicates and the graphs are representative of three independent experiments. Student t-test indicates ** p-value < 0.01; **** p-value < 0.001.
Figure 5BisPMB induces time dependent MAPK activation in WHCO1 cells. (A) WHCO1 cells were treated with bisPMB (IC50 concentration) for up to 24 h. The cell lysate was collected and analysed by immunoblot probed with anti-phosphorylated JNK1/2 and total anti-JNK1/2 primary antibodies. (B) WHCO1 cells were pre-treated with SP600125 at the indicated concentration for 30 min followed by the addition of bisPMB (IC50 concentration) for 8 h. The cell lysate was collected and analysed by immunoblot probed with anti-phosphorylated JNK1/2 and total anti-JNK1/2 primary antibodies. (C) WHCO1 cells were pre-treated with 30 µM SP600125 for 30 min followed by the addition of bisPMB (IC50 concentration) for 24 h. Cell viability was then quantified by the MTT cytotoxicity assay. (D) WHCO1 cells were treated with bisPMB (IC50 concentration) for up to 16 h. The cell lysate was collected and analysed by immunoblot probed with anti-phosphorylated ERK1/2 and total anti-ERK2 primary antibodies. (E) WHCO1 cells were pre-treated with U0126 at the indicated concentration for 2 h followed by the addition of bisPMB (IC50 concentration) for 30 min. The cell lysate was collected and analysed by immunoblot probed with anti-phosphorylated ERK1/2 and total anti-ERK2 primary antibodies. (F) WHCO1 cells were pre-treated with 10 µM U0126 for 2 h followed by bisPMB (IC50 concentration) for 24 h. Cell viability was then quantified by the MTT cytotoxicity assay. Immunoblots shown are representative of two independent experiments. Each bar represents the average absorbance reading from three technical replicates and the experiment was performed in dependently in triplicate. Student t-test indicates * p-value < 0.05; *** p-value < 0.005; **** p-value < 0.001.